What is Guggenheim's price target for MRSN?

Guggenheim's latest stated price target for Mersana Therapeutics Inc. (MRSN) is $7, from its action on Feb 29, 2024.

What is Guggenheim's rating on MRSN?

Guggenheim rates MRSN Buy, a bullish rating, as of Feb 29, 2024.

When did Guggenheim last change its view on MRSN?

On Feb 29, 2024, Guggenheim upgrades to Buy from Neutral, price target $7.

Guggenheim MRSN price target and rating history

Mersana Therapeutics Inc. (MRSN) · Health Care

Guggenheim rates Mersana Therapeutics Inc. (MRSN) Buy with a $7 price target, as of its latest action on Feb 29, 2024. It has published 3 rating actions on MRSN since June 2023, including 1 upgrade and 1 downgrade.

Current rating: Buy
Price target: $7
Median target, all firms: Too few
Actions on MRSN: 3

Guggenheim price target on MRSN

Guggenheim price target on MRSN, each point a stated target, June 2023 to February 2024.

Every Guggenheim rating on MRSN

Feb 29, 2024
UpgradeGuggenheim upgrades to Buy from Neutral, price target $7
Jul 27, 2023
DowngradeGuggenheim downgrades to Neutral from Buy
Jun 15, 2023
InitiateGuggenheim starts coverage at Buy, price target $14

Questions about Guggenheim and MRSN

What is Guggenheim's price target for MRSN?: Guggenheim's latest stated price target for Mersana Therapeutics Inc. (MRSN) is $7, from its action on Feb 29, 2024.
What is Guggenheim's rating on MRSN?: Guggenheim rates MRSN Buy, a bullish rating, as of Feb 29, 2024.
When did Guggenheim last change its view on MRSN?: On Feb 29, 2024, Guggenheim upgrades to Buy from Neutral, price target $7.

More MRSN rating histories

All Guggenheim ratings MRSN news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.